BOSTON, May 9, 2017 /PRNewswire/ -- CSA Medical today announced new clinical data related to its truFreeze® SprayCryotherapy (SCT) system to be presented in a series of oral and poster presentations at Digestive Disease Week® (DDW) 2017 in Chicago, Illinois.
"The variety of truFreeze Liquid Nitrogen Spray Cryotherapy
The schedule for the clinical symposium and posters related to truFreeze® Spray Cryotherapy is presented below:
Sunday, May 7Clinical Symposium – Sp360 - Ablation for Barrett's: RFA, Cryo or Both?Presenter: John Dumot, MD, Ahuja Hospital, University of Cleveland Health System
Tuesday, May 9Posters - 12:00 – 2:00 pm - South Hall, McCormick Place
Session 9015, Tu1156 - Long-Term Outcomes of Patients with Barrett's Esophagus Non-Responsive to Radiofrequency AblationInvestigators: Kavel Visrodia, Akhil Nehra, Liam Zakko, Daniel Chan, Cadman Leggett, Michele Johnson, Prasad Iyer, Lori Lutzke, Kenneth Wang
Session 9015, poster Tu1158 - Significance of Positive Lateral and/or Deep Margins Following Endoscopic Resection and Liquid Nitrogen Spray Cryotherapy in pT1 Esophageal AdenocarcinomaInvestigators: Fariha Ramay, Bruce D. Greenwald
Session 9015, poster Tu1160 - Evaluation of Pain and Dysphagia in Patients Undergoing Cryoablation or Radiofrequency Ablation for Barrett's Esophagus: A Prospective Multicenter AssessmentInvestigators: Sanjeev Solomon, Arvind Julius Trindade, Shivangi Kothari, Vivek Kaul, Sumant Inamdar, Peter Stein, Viviana Alejandra Rodriquez, Krystle Bittner, Alvin M. Zfass, George Smallfield
Session 9015, poster Tu1166 - Liquid Nitrogen Spray Cryotherapy Effectively Eradicates Barrett's Esophagus Irrespective of Severity of Baseline Histology: Results of a U.S. Multicenter Registry Investigators: Swathi Eluri, Cary C. Cotton, Vivek Kaul, Virendra Joshi, Brenda J. Hoffman, Nicholas J. Shaheen
Session 9020, poster Tu1256 - Impact of Liquid Nitrogen Endoscopic Spray Cryotherapy on Overall Survival in Metastatic Esophageal CancerInvestigators: Ravi Prakash, Toufic Kachaamy, Michele Ambrosius, Tess Magat, Joon Soo Shin, Digant Gupta, Pankaj G. Vashi
About CSA Medical CSA Medical, Inc. develops and manufactures a proprietary interventional spray cryotherapy technology platform utilizing unique properties of liquid nitrogen spray delivered by a software driven device with specialty catheters that enable delivery of spray cryogen inside the body to flash freeze and destroy unwanted tissue allowing for a rejuvenative pattern of healing. CSA manufactures and distributes this technology in the USA as the truFreeze® system which is currently used to ablate unwanted benign and malignant tissue.
To learn more about our technology, please visit www.csamedical.com.
truFreeze is a registered trademark of CSA Medical, Inc.
Media Contact:Amy Sarli781-538-4779
Press release distributed by PRLog
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/csa-medical-announces-presentations-of-trufreeze-clinical-studies-at-digestive-disease-week-300453887.html
SOURCE CSA Medical
Subscribe to our Free Newsletters!
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...
Statins are a group of drugs which help to lower the blood cholesterol levels.View All